160 Health (02656) has announced that its domestic subsidiary has successfully delivered an integrated solution valued at RMB 12.2 million to a health-focused enterprise specializing in smart wearable devices, with acceptance documentation already secured. The customer and its ultimate beneficial owners are, to the best of the board's knowledge, independent third parties unconnected to the company or its affiliated entities.
This order encompasses a comprehensive suite that includes a smart health monitoring system, computing infrastructure, and integration and commissioning services. Upon completion of delivery, the solution is designed to support real-time ingestion, cleaning, and storage of high-frequency biometric data from the customer's vast array of endpoint devices. Leveraging the computing power, it enables core functions such as AI-driven health inference, risk alerting, and user health profile management.
The group has long been entrenched in the internet healthcare sector, amassing substantial expertise in medical and health services, along with a robust portfolio of intellectual property, including numerous invention patents and software copyrights. Building on its established platform, the company has upgraded its offerings by deeply integrating AI applications to develop the 160AI Hospital and has pioneered a new operational partnership model under the same name, consistently advancing the deployment of AI agents within medical settings. Currently, the group has established an integrated "platform + AI agent + operations" framework, embedding AI agents across its internal operations—spanning product development, content generation, and customer service—thereby markedly boosting overall operational efficiency and professional service capabilities.
To capitalize on the market opportunities arising from the convergence of AI technology and healthcare, the group is extending its existing business by merging its proprietary smart health monitoring systems with computing infrastructure. This has led to the creation of a holistic "medical AI agent + hardware + integration and commissioning services" solution, delivering AI-enabled medical products alongside computing infrastructure to clients in the healthcare sector, and further diversifying the group's product portfolio. The board views the successful delivery and acceptance of this solution as a pivotal milestone and a critical breakthrough in charting a new business trajectory at the intersection of healthcare and AI computing.
The group notes that as AI technology permeates the healthcare industry with growing intensity, downstream demand for integrated "AI application + computing infrastructure" deliveries is progressively emerging. Particularly in scenarios such as smart wearable health monitoring and chronic disease management, the synergistic deployment of AI software platforms and computing infrastructure has become a vital element for healthcare enterprises to achieve complete business loops. By combining its proprietary software capabilities with computing infrastructure, the group is poised to deliver more valuable digital healthcare solutions to clients with specific needs, thereby broadening its business scope and service depth. This strategic move advances the company towards its goal of transitioning from a "comprehensive digital healthcare service platform" to a "medical AI agent ecosystem infrastructure and operations service provider," while also diversifying its revenue streams.